Whole-animal cellular and molecular imaging to accelerate drug development
- PMID: 12047855
- DOI: 10.1016/s1359-6446(02)02268-7
Whole-animal cellular and molecular imaging to accelerate drug development
Abstract
In the past decade, new technologies (genomics), chemistries and high-throughput (HT) in vitro assays have played a large role in changing the paradigm of drug discovery and development. These technologies have enabled many more targets and potential lead compounds to be introduced into drug development. However, since 1996, the number of drug approvals per year has been decreasing. This reduced pipeline has now compromised the ability of biopharmaceutical companies to deliver the double-digit growth levels that investors expect. This review explores what is lacking in the drug discovery and development process that has caused such a dearth of new chemical entities (NCEs), and looks at how new in vivo imaging technologies might provide an answer in the form of more predictive animal models.
Comment in
-
The use of imaging to accelerate drug development.Drug Discov Today. 2002 Jul 1;7(13):706-7. doi: 10.1016/s1359-6446(02)02342-5. Drug Discov Today. 2002. PMID: 12110224 No abstract available.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Anticancer drug discovery using chemical genomics.Curr Med Chem. 2003 May;10(9):749-55. doi: 10.2174/0929867033457764. Curr Med Chem. 2003. PMID: 12678778 Review.
-
Toxicogenomics and drug discovery: will new technologies help us produce better drugs?Nat Rev Drug Discov. 2002 Jan;1(1):84-8. doi: 10.1038/nrd710. Nat Rev Drug Discov. 2002. PMID: 12119613 Review.
-
Synthetic approaches to the 2004 new drugs.Mini Rev Med Chem. 2005 Dec;5(12):1133-44. doi: 10.2174/138955705774933329. Mini Rev Med Chem. 2005. PMID: 16375759 Review.
-
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S45-56. doi: 10.1007/s00280-003-0593-0. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12819933 Review.
Cited by
-
Photonic plasmid stability of transformed Salmonella typhimurium: a comparison of three unique plasmids.BMC Microbiol. 2009 Jul 27;9:152. doi: 10.1186/1471-2180-9-152. BMC Microbiol. 2009. PMID: 19635131 Free PMC article.
-
In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.Clin Exp Metastasis. 2003;20(8):745-56. doi: 10.1023/b:clin.0000006817.25962.87. Clin Exp Metastasis. 2003. PMID: 14713108
-
Recent advances in small-animal cardiovascular imaging.J Nucl Med. 2009 May;50(5):667-70. doi: 10.2967/jnumed.108.058479. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372476 Free PMC article. Review.
-
Bioluminescence Tomography-Guided Radiation Therapy for Preclinical Research.Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1144-53. doi: 10.1016/j.ijrobp.2015.11.039. Epub 2015 Dec 14. Int J Radiat Oncol Biol Phys. 2016. PMID: 26876954 Free PMC article.
-
In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.Cancer Immunol Immunother. 2012 Oct;61(10):1617-26. doi: 10.1007/s00262-012-1219-3. Epub 2012 Feb 19. Cancer Immunol Immunother. 2012. PMID: 22350071 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
